Anaphylatoxins in preterm and term labor

Journal of Perinatal Medicine

Volumn 33, Issue 4, 2005, Pages 306-313

  Soto, Eleazar ^a,b   Romero, Roberto ^a,d   Richani, Karina ^a,b   Espinoza, Jimmy ^a,b   Nien, Jyh Kae ^a   Chaiworapongsa, Tinnakorn ^a,b   Santolaya Forgas, Joaquin ^a,b   Edwin, Samuel S ^a   Mazor, Moshe ^c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d HUTZEL HOSPITAL   (United States)

Author keywords

Anaphylatoxin; C3a; C4a; C5a; Human labor; Intraamniotic infection; Parturition; Preterm labor

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C5A;

ADOLESCENT; ADULT; ARTICLE; BLOOD ANALYSIS; CHILDBIRTH; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LABOR; MAJOR CLINICAL STUDY; MATERNAL PLASMA; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; ANAPHYLATOXINS; COMPLEMENT C3A; COMPLEMENT C4A; COMPLEMENT C5A; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LABOR, OBSTETRIC; OBSTETRIC LABOR, PREMATURE; PREGNANCY; STATISTICS, NONPARAMETRIC;

EID: 23944464960     PISSN: 03005577     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPM.2005.051     Document Type: Article

References (60)

1. Ahmed AE, JB Peter: Clinical utility of complement assessment. Clin Diagn Lab Immunol 2 (1995) 509
2. Albrecht EA, AM Chinnaiyan, S Varambally, C Kumar-Sinha, TR Barrette, JV Sarma, PA Ward: C5a-induced gene expression in human umbilical vein endothelial cells. Am J Pathol 164 (2004) 849
3. Alexander GR, JH Himes, RB Kaufman, J Mor, M Kogan: A United States national reference for fetal growth. Obstet Gynecol 87 (1996) 163
4. Amon E: Preterm Labor. In: Reece E, Hobbins J: Medicine of the Fetus and Mother. Lippincontt-Robin, Philladelphia 1999
5. Carroll MC: The complement system in regulation of adaptive immunity. Nat Immunol 5 (2004) 981
6. Cochrane CG, HJ Muller-Eberhard: The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J Exp Med 127 (1968) 371
7. Czermak BJ, V Sarma, CL Pierson, RL Warner, M Huber-Lang, NM Bless, H Schmal, HP Friedl, PA Ward: Protective effects of C5a blockade in sepsis. Nat Med 5 (1999) 788
8. Daffern PJ, PH Pfeifer, JA Ember, TE Hugli: C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med 181 (1995) 2119
9. Dias DS, IH Lepow: Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement. J Exp Med 125 (1967) 921
10. Ehrengruber MU, T Geiser, DA Deranleau: Activation of human neutrophils by C3a and C5A. Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burst. FEBS Lett 346 (1994) 181
11. Ember JA, MA Jagels, TE Hugli: Characterization of Complement Anaphylatoxins and Their Biological Responses. In: Volanakis JE, Frank MM: The Human Complement System in Health and Disease. Marcel Dekker, INC., New York 1998
12. Ember JA, SD Sanderson, TE Hugli, EL Morgan: Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am J Pathol 144 (1994) 393
13. Foreman KE, AA Vaporciyan, BK Bonish, ML Jones, KJ Johnson, MM Glovsky, SM Eddy, PA Ward: C5a-induced expression of P-selectin in endothelial cells. J Clin Invest 94 (1994) 1147
14. Foulder-Hughes LA, RWI Cooke: Motor, cognitive, and behavioural disorders in children born very preterm. Developmental Medicine and Child Neurology 45 (2003) 97
15. Gasque P: Complement: a unique innate immune sensor for danger signals. Mol Immunol 41 (2004) 1089
16. Gervasi MT, T Chaiworapongsa, N Naccasha, S Blackwell, BH Yoon, E Maymon, R Romero: Phenotypic and metabolic characteristics of maternal monocytes and granulocytes in preterm labor with intact membranes. Am J Obstet Gynecol 185 (2001) 1124
17. Gervasi MT, T Chaiworapongsa, N Naccasha, P Pacora, S Berman, E Maymon, JC Kim, YM Kim, J Yoshimatsu, J Espinoza, R Romero: Maternal intravascular inflammation in preterm premature rupture of membranes. J Matern Fetal Neonatal Med 11 (2002) 171
18. Girardi G, J Berman, P Redecha, L Spruce, JM Thurman, D Kraus, TJ Hollmann, P Casali, MC Caroll, RA Wetsel, JD Lambris, VM Holers, JE Salmon: Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 112 (2003) 1644
19. Goldstein IM, D Roos, HB Kaplan, G Weissmann: Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis. J Clin Invest 56 (1975) 1155
20. Gomez R, F Ghezzi, R Romero, H Munoz, JE Tolosa, I Rojas: Premature labor and intra-amniotic infection. Clinical aspects and role of the cytokines in diagnosis and pathophysiology. Clin Perinatol 22 (1995) 281
21. Gorski JP, TE Hugli, HJ Muller-Eberhard: C4a: the third anaphylatoxin of the human complement system. Proc Natl Acad Sci USA 76 (1979) 5299
22. Grant EP, D Picarella, T Burwell, T Delaney, A Croci, N Avitahl, AA Humbles, JC Gutierrez-Ramos, M Briskin, C Gerard, AJ Coyle: Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis. J Exp Med 196 (2002) 1461
23. Haeger M, M Unander, B Norder-Hansson, M Tylman, A Bengtsson: Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 79 (1992) 19
24. Hartmann K, BM Henz, S Kruger-Krasagakes, J Kohl, R Burger, S Guhl, I Haase, U Lippert, T Zuberbier: C3a and C5a stimulate chemotaxis of human mast cells. Blood 89 (1997) 2863
25. Hebisch G, PM Neumaier-Wagner, R Huch, U von Mandach: Maternal serum interleukin-1 beta, -6 and -8 levels and potential determinants in pregnancy and peripartum. J Perinat Med 32 (2004) 475
26. Huber-Lang M, EM Younkin, JV Sarma, N Riedemann, SR McGuire, KT Lu, R Kunkel, JG Younger, FS Zetoune, PA Ward: Generation of C5a by phagocytic cells. Am J Pathol 161 (2002) 1849
27. Huffaker J, SS Witkin, L Cutler, ML Druzin, WJ Ledger: Total complement activity in maternal sera, amniotic fluids and cord sera in women with premature labor, premature rupture of membranes or chorioamnionitis. Surg Gynecol Obstet 168 (1989) 397
28. Humbles AA, B Lu, CA Nilsson, C Lilly, E Israel, Y Fujiwara, NP Gerard, C Gerard: A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 406 (2000) 998
29. Jagels MA, PJ Daffern, TE Hugli: C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion. Immunopharmacology 46 (2000) 209
30. Keelan JA, M Blumenstein, RJ Helliwell, TA Sato, KW Marvin, MD Mitchell: Cytokines, prostaglandins and parturition -a review. Placenta 24 Suppl A (2003) S33
31. Kelly RW: Inflammatory mediators and parturition. Rev Reprod 1 (1996) 89
32. Kovar IZ, PG Riches: C3 and C4 complement components and acute phase proteins in late pregnancy and parturition. J Clin Pathol 41 (1988) 650
33. Mathews TJ, F Menacker, MF MacDorman: Infant mortality statistics from the 2002 period: linked birth/infant death data set. Natl Vital Stat Rep 53 (2004) 1
34. Medzhitov R, CA Janeway, Jr.: Decoding the patterns of self and nonself by the innate immune system. Science 296 (2002) 298
35. Moxley G, S Ruddy: Elevated plasma C3 anaphylatoxin levels in rheumatoid arthritis patients. Arthritis Rheum 30 (1987) 1097
36. Nakae H, S Endo, K Inada, M Yoshida: Chronological changes in the complement system in sepsis. Surg Today 26 (1996) 225
37. Nakano Y, S Morita, A Kawamoto, T Suda, K Chida, H Nakamura: Elevated complement C3a in plasma from patients with severe acute asthma. J Allergy Clin Immunol 112 (2003) 525
38. Okusawa S, CA Dinarello, KB Yancey, S Endres, TJ Lawley, MM Frank, JF Burke, JA Gelfand: C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferongamma. J Immunol 139 (1987) 2635
39. Okusawa S, KB Yancey, JW van der Meer, S Endres, G Lonnemann, K Hefter, MM Frank, JF Burke, CA Dinarello, JA Gelfand: C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha. J Exp Med 168 (1988) 443
40. Perianayagam MC, VS Balakrishnan, AJ King, BJ Pereira, BL Jaber: C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway. Kidney Int 61 (2002) 456
41. Richani K, E Soto, J Espinoza, J Nien, T Chaiworapongsa, S Edwin, M Mazor, R Romero: Normal pregnancy is characterized by systemic complement activation of the complement system. Am J Obstet Gynecol 191 (2004) S139 (abstract)
42. Riedemann NC, RF Guo, TJ Hollmann, H Gao, TA Neff, JS Reuben, CL Speyer, JV Sarma, RA Wetsel, FS Zetoune, PA Ward: Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J 18 (2004) 370
43. Romero R, J Espinoza, M Mazor, T Chaiworapongsa: The preterm parturition syndrome. In: Critchley C, Bennet P, Thornton S: Preterm Birth. RCOG Press, London 2004
44. Schindler R, JA Gelfand, CA Dinarello: Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself. Blood 76 (1990) 1631
45. Scholz W, MR McClurg, GJ Cardenas, M Smith, DJ Noonan, TE Hugli, EL Morgan: C5a-mediated release of interleukin 6 by human monocytes. Clin Immunol Immunopathol 57 (1990) 297
46. Schumacher WA, JC Fantone, SE Kunkel, RC Webb, BR Lucchesi: The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculature in vitro and in vivo. Agents Actions 34 (1991) 345
47. Shin HS, R Snyderman, E Friedman, A Mellors, MM Mayer: Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement. Science 162 (1968) 361
48. Siegel I, N Gleicher: Peripheral white blood cell alterations in early labor. Diagn Gynecol Obstet 3 (1981) 123
49. Slattery MM, JJ Morrison: Preterm delivery. Lancet 360 (2002) 1489
50. Stevens JH, P O'Hanley, JM Shapiro, FG Mihm, PS Satoh, JA Collins, TA Raffin: Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J Clin Invest 77 (1986) 1812
51. Takafuji S, K Tadokoro, K Ito, CA Dahinden: Degranulation from human eosinophils stimulated with C3a and C5a. Int Arch Allergy Immunol 104 Suppl 1 (1994) 27
52. Thomson AJ, JF Telfer, A Young, S Campbell, CJ Stewart, IT Cameron, IA Greer, JE Norman: Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process. Hum Reprod 14 (1999) 229
53. Vogt W: Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes. Immunobiology 195 (1996) 334
54. Vogt W: Cleavage of the fifth component of complement and generation of a functionally active C5b6-like complex by human leukocyte elastase. Immunobiology 201 (2000) 470
55. Volanakis JE: Overview of the Complement System. In: Volanakis JE, Frank MM: The Human Complement System in Health and Disease. Marcel Dekker, Inc., New York 1998
56. Walport MJ: Complement. First of two parts. N Engl J Med 344 (2001) 1058
57. Ward PA: The dark side of C5a in sepsis. Nat Rev Immunol 4 (2004) 133
58. Ward PA, JH Hill: C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J Immunol 104 (1970) 535
59. Woodruff TM, TV Arumugam, IA Shiels, RC Reid, DP Fairlie, SM Taylor: Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in rats. J Surg Res 116 (2004) 81
60. Wymann MP, P Kernen, DA Deranleau, M Baggiolini: Respiratory burst oscillations in human neutrophils and their correlation with fluctuations in apparent cell shape. J Biol Chem 264 (1989) 15829